These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 12721928)

  • 1. Monitoring vaccine safety during measles mass immunization campaigns: clinical and programmatic issues.
    Pless RP; Bentsi-Enchill AD; Duclos P
    J Infect Dis; 2003 May; 187 Suppl 1():S291-8. PubMed ID: 12721928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ensuring injection safety during measles immunization campaigns: more than auto-disable syringes and safety boxes.
    Hersh BS; Carr RM; Fitzner J; Goodman TS; Mayers GF; Everts H; Laurent E; Larsen GA; Bilous JB
    J Infect Dis; 2003 May; 187 Suppl 1():S299-306. PubMed ID: 12721929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles-rubella mass immunization campaign in Albania, November 2000.
    Bino S; Kakarriqi E; Xibinaku M; Ion-Nedelcu N; Bukli M; Emiroglu N; Uzicanin A
    J Infect Dis; 2003 May; 187 Suppl 1():S223-9. PubMed ID: 12721917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The challenge of achieving measles elimination in the eastern Mediterranean region by 2010.
    Gaafar T; Moshni E; Lievano F
    J Infect Dis; 2003 May; 187 Suppl 1():S164-71. PubMed ID: 12721909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress toward measles eradication in the region of the Americas.
    De Quadros CA; Izurieta H; Carrasco P; Brana M; Tambini G
    J Infect Dis; 2003 May; 187 Suppl 1():S102-10. PubMed ID: 12721900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of a computerized database to monitor vaccine safety in Viet Nam.
    Ali M; Canh GD; Clemens JD; Park JK; von Seidlein L; Minh TT; Thiem DV; Tho HL; Trach DD;
    Bull World Health Organ; 2005 Aug; 83(8):604-10. PubMed ID: 16193545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in global measles control and mortality reduction, 2000-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Dec; 57(48):1303-6. PubMed ID: 19052529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two doses of measles vaccine reduce measles dealths.
    van den Ent M; Gupta SK; Hoekstra E
    Indian Pediatr; 2009 Nov; 46(11):933-8. PubMed ID: 19955576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience in global measles control, 1990-2001.
    Henao-Restrepo AM; Strebel P; John Hoekstra E; Birmingham M; Bilous J
    J Infect Dis; 2003 May; 187 Suppl 1():S15-21. PubMed ID: 12721887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles eradication in the Americas: experience in Haiti.
    Venczel L; Dobbins J; André J; Laender F; Izurieta H; Delorme P; Voltaire HC
    J Infect Dis; 2003 May; 187 Suppl 1():S127-32. PubMed ID: 12721903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The unfinished measles immunization agenda.
    Strebel P; Cochi S; Grabowsky M; Bilous J; Hersh BS; Okwo-Bele JM; Hoekstra E; Wright P; Katz S
    J Infect Dis; 2003 May; 187 Suppl 1():S1-7. PubMed ID: 12721885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of a mass measles campaign in central Afghanistan, December 2001 to May 2002.
    Dadgar N; Ansari A; Naleo T; Brennan M; Salama P; Sadozai N; Golaz A; Lievano F; Jafari H; Mubarak M; Hoekstra E; Paganini A; Feroz F
    J Infect Dis; 2003 May; 187 Suppl 1():S186-90. PubMed ID: 12721912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass measles immunization campaign: experience in the Hong Kong Special Administrative Region of China.
    Chuang SK; Lau YL; Lim WL; Chow CB; Tsang T; Tse LY
    Bull World Health Organ; 2002; 80(7):585-91. PubMed ID: 12163924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of alternative approaches to accelerated measles control: experience in the African region, 1996-2002.
    Otten MW; Okwo-Bele JM; Kezaala R; Biellik R; Eggers R; Nshimirimana D
    J Infect Dis; 2003 May; 187 Suppl 1():S36-43. PubMed ID: 12721884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of accurate diagnosis in the assessment of impact of immunisation campaigns: case study of a measles immunisation programme in Madagascar.
    Garry SF
    Public Health; 2009 Jan; 123(1):72-3. PubMed ID: 19049839
    [No Abstract]   [Full Text] [Related]  

  • 17. Measles epidemiology and elimination strategies in Turkey.
    Güriş D; Bayazit Y; Ozdemirer U; Buyurgan V; Yalniz C; Toprak I; Aycan S
    J Infect Dis; 2003 May; 187 Suppl 1():S230-4. PubMed ID: 12721918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress towards elimination of measles in the Americas. WHO expanded programme on immunization.
    Can Commun Dis Rep; 1998 Jun; 24(11):94-6. PubMed ID: 9629836
    [No Abstract]   [Full Text] [Related]  

  • 19. Progress toward measles elimination--Southern Africa, 1996-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jul; 48(27):585-9. PubMed ID: 10428097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of unfounded vaccine safety concerns on the nationwide measles-rubella immunization campaign, Georgia, 2008.
    Khetsuriani N; Imnadze P; Baidoshvili L; Jabidze L; Tatishili N; Kurtsikashvili G; Lezhava T; Laurent E; Martin R
    Vaccine; 2010 Sep; 28(39):6455-62. PubMed ID: 20674880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.